Pharmacopsychiatry

Top Research Topics at Pharmacopsychiatry?

The objective of the journal is to combine knowledge in the areas of Psychiatry, Internal medicine, Pharmacology, Endocrinology and Anesthesia. The journal facilitates discussions in Depression (differential diagnoses), Schizophrenia and Antipsychotic as part of the larger field of Psychiatry, however, it also tackles fields such as In patient. The studies tackled, which mainly focus on Schizophrenia, apply to Psychosis as well.

The journal explores topics in Internal medicine which can be helpful for research in disciplines like Antidepressant, Placebo and Gastroenterology. It emphasizes research on Pharmacology, which includes concerns such as Drug.

• Psychiatry (25.18%)
• Internal medicine (23.56%)
• Pharmacology (15.66%)

What are the most cited papers published in the journal?

• AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011 (638 citations)
• Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017. (438 citations)
• Course of the manic-depressive cycle and changes caused by treatments (383 citations)

Research areas of the most cited articles at Pharmacopsychiatry:

The published articles are organized to reinforce research efforts on Internal medicine, Psychiatry, Pharmacology, Endocrinology and Anesthesia. The journal papers hold forums on Psychiatry that merge themes from other disciplines such as Pediatrics and Clinical psychology. The journal papers address concerns in the field of Pharmacology by exploring it in line with topics in Antidepressant which intersect with Mechanism of action subjects.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Diabetes mellitus

The previous edition focused in particular on these issues:

The journal investigates studies in Internal medicine, Psychiatry, Antidepressant, Antipsychotic and MEDLINE. Topics in Internal medicine explored in the journal were investigated in conjunction with research in Venlafaxine, Endocrinology and Psychosis. Among the topics covered in the journal are Psychiatry and Front page.

Research in the field of Depression (differential diagnoses) was used to conduct the presented Antidepressant study. The journal focuses on Antipsychotic but the discussions also offer insight into other areas such as Quetiapine, Bipolar disorder, Olanzapine and Positive and Negative Syndrome Scale. While work presented in Pharmacopsychiatry provided substantial information on MEDLINE, it also covered topics in Patient subgroups, Treatment goals and Family medicine.

The most cited articles from the last journal are:

• Review and Consensus on Pharmacogenomic Testing in Psychiatry (21 citations)
• The History of Psychedelics in Psychiatry. (6 citations)
• Neurotrophic Properties of Silexan, an Essential Oil from the Flowers of Lavender-Preclinical Evidence for Antidepressant-Like Properties. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Pharmacopsychiatry (based on the number of publications) are:

• H.-J. Möller (133 papers) absent at the last edition,
• Florian Holsboer (120 papers) absent at the last edition,
• Manfred Uhr (66 papers) absent at the last edition,
• E Haen (62 papers) absent at the last edition,
• Ulrich Hegerl (61 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Pharmacopsychiatry (based on the number of publications) are:

• Max Planck Society (346 papers) absent at the last edition,
• Ludwig Maximilian University of Munich (110 papers) published 1 paper at the last edition the same number as at the previous edition,
• Free University of Berlin (83 papers) published 1 paper at the last edition,
• Charité (62 papers) published 4 papers at the last edition, 1 less than at the previous edition,
• University of Mainz (52 papers) published 2 papers at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 10.00% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 33.33% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.11% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 22.22% of all publications and 33.33% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Requirements and Process for Publishing in the Journal

In order to publish an article in our journal, authors should follow a set observation and submission process that upholds the integrity of research in the field of Pharmacopsychiatry. The first step in this process involves fulfilling specific educational and vocational prerequisites. This includes acquiring a south carolina nursing license requirements, along with having considerable experience in the fields of Psychiatry, Internal medicine, Pharmacology, Endocrinology, or Anesthesia.

After meeting these requirements, researchers should ensure that their study adheres to the ethical standards set by the field and our journal. This includes obtaining informed consent from all subjects involved in their study, as well as ensuring the confidentiality and anonymity of said subjects. The research design and methods should also uphold the principles of autonomy, beneficence, non-maleficence, justice, and honesty.

Manuscripts submitted for review should clearly state the study's objectives, research design, methodology, results, and discussion. The language should be clear, concise, and free of jargon. The text should also comply with APA style guidelines, and all sources and references should be properly cited in the text and included in the references list. After submission, the manuscript will undergo a peer review process before it is accepted for publication.

Above all, we value studies that contribute meaningful insights and innovations to the fields our journal covers. We believe that rigorous and principled research can pave the way for progress and advancements in Pharmacopsychiatry and its related disciplines.